Previously undetected human hematopoietic cell populations with short-term repopulating activity selectively engraft NOD/SCID-beta2 microglobulin-null mice.

Increasing use of purified or cultured human hematopoietic cells as transplants has revealed an urgent need for better methods to predict the speed and durability of their engraftment potential. We now show that NOD/SCID-beta2 microglobulin-null (NOD/SCID-beta2m-/-) mice are sequentially engrafted by two distinct and previously unrecognized populations of transplantable human short-term repopulating hematopoietic cells (STRCs), neither of which efficiently engraft NOD/SCID mice. One is predominantly CD34+CD38+ and is myeloid-restricted; the other is predominantly CD34+CD38- and has broader lymphomyeloid differentiation potential. In contrast, the long-term repopulating human cells that generate lymphoid and myeloid progeny in NOD/SCID mice engraft and self-renew in NOD/SCID-beta2m-/- mice equally efficiently. In short-term expansion cultures of adult bone marrow cells, myeloid-restricted STRCs were preferentially amplified (greater than tenfold) and, interestingly, both types of STRC were found to be selectively elevated in mobilized peripheral blood harvests. These results suggest an enhanced sensitivity of STRCs to natural killer cell-mediated rejection. They also provide new in vivo assays for different types of human STRC that may help to predict the engraftment potential of clinical transplants and facilitate future investigation of early stages of human hematopoietic stem cell differentiation.

[1]  C. Eaves,et al.  Human hematopoietic stem cells stimulated to proliferate in vitro lose engraftment potential during their S/G(2)/M transit and do not reenter G(0). , 2000, Blood.

[2]  J. Tisdale,et al.  Many multipotential gene-marked progenitor or stem cell clones contribute to hematopoiesis in nonhuman primates. , 2000, Blood.

[3]  H. Ben‐Hur,et al.  β2 Microglobulin-deficient (B2mnull) NOD/SCID mice are excellent recipients for studying human stem cell function , 2000 .

[4]  B. Grimes,et al.  Effects of cell cycle activation on the short-term engraftment properties of ex vivo expanded murine hematopoietic cells. , 2000, Blood.

[5]  I. Weissman,et al.  A clonogenic common myeloid progenitor that gives rise to all myeloid lineages , 2000, Nature.

[6]  C. Eaves,et al.  High marrow seeding efficiency of human lymphomyeloid repopulating cells in irradiated NOD/SCID mice. , 2000, Blood.

[7]  K. Ando,et al.  Ex vivo generation of CD34(+) cells from CD34(-) hematopoietic cells. , 1999, Blood.

[8]  P. V. van Hennik,et al.  Seeding efficiency of primitive human hematopoietic cells in nonobese diabetic/severe combined immune deficiency mice: implications for stem cell frequency assessment. , 1999, Blood.

[9]  C. Eaves,et al.  Unique differentiation programs of human fetal liver stem cells shown both in vitro and in vivo in NOD/SCID mice. , 1999, Blood.

[10]  C. Eaves,et al.  Functional differences between transplantable human hematopoietic stem cells from fetal liver, cord blood, and adult marrow. , 1999, Experimental hematology.

[11]  J. Dick,et al.  Cytokine treatment or accessory cells are required to initiate engraftment of purified primitive human hematopoietic cells transplanted at limiting doses into NOD/SCID mice , 1999, Bone Marrow Transplantation.

[12]  D. Clapp,et al.  Cell cycle-related changes in repopulating capacity of human mobilized peripheral blood CD34(+) cells in non-obese diabetic/severe combined immune-deficient mice. , 1998, Blood.

[13]  David A. Williams,et al.  Nonobese diabetic/severe combined immunodeficiency (NOD/SCID) mouse as a model system to study the engraftment and mobilization of human peripheral blood stem cells. , 1998, Blood.

[14]  J. Dick,et al.  A newly discovered class of human hematopoietic cells with SCID-repopulating activity , 1998, Nature Medicine.

[15]  J. Wuu,et al.  The Fluctuating Phenotype of the Lymphohematopoietic Stem Cell with Cell Cycle Transit , 1998, The Journal of experimental medicine.

[16]  S. Nishikawa,et al.  In vitro generation of lymphohematopoietic cells from endothelial cells purified from murine embryos. , 1998, Immunity.

[17]  M. Ogawa,et al.  Human bone marrow CD34- cells engraft in vivo and undergo multilineage expression that includes giving rise to CD34+ cells. , 1998, Experimental hematology.

[18]  I. Weissman,et al.  Identification of Clonogenic Common Lymphoid Progenitors in Mouse Bone Marrow , 1997, Cell.

[19]  N. Iscove,et al.  Hematopoietic stem cells expand during serial transplantation in vivo without apparent exhaustion , 1997, Current Biology.

[20]  C. Eaves,et al.  Expansion in vitro of transplantable human cord blood stem cells demonstrated using a quantitative assay of their lympho-myeloid repopulating activity in nonobese diabetic-scid/scid mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[21]  C. Eaves,et al.  Sustained proliferation, multi‐lineage differentiation and maintenance of primitive human haemopoietic cells in NOD/SCID mice transplanted with human cord blood , 1997, British journal of haematology.

[22]  J. Dick,et al.  Kinetic evidence of the regeneration of multilineage hematopoiesis from primitive cells in normal human bone marrow transplanted into immunodeficient mice. , 1997, Blood.

[23]  J. Dick,et al.  Primitive human hematopoietic cells are enriched in cord blood compared with adult bone marrow or mobilized peripheral blood as measured by the quantitative in vivo SCID-repopulating cell assay. , 1997, Blood.

[24]  J. Dick,et al.  Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[25]  D. Roopenian,et al.  Enhanced human CD4+ T cell engraftment in beta2-microglobulin-deficient NOD-scid mice. , 1997, Journal of immunology.

[26]  L. To,et al.  The biology and clinical uses of blood stem cells. , 1997, Blood.

[27]  C. Civin,et al.  Sustained, retransplantable, multilineage engraftment of highly purified adult human bone marrow stem cells in vivo. , 1996, Blood.

[28]  W. Vainchenker,et al.  Phenotype and function of human hematopoietic cells engrafting immune-deficient CB17-severe combined immunodeficiency mice and nonobese diabetic-severe combined immunodeficiency mice after transplantation of human cord blood mononuclear cells. , 1996, Blood.

[29]  S. E. Brodie.  New York, New York, USA , 1996 .

[30]  I. Weissman,et al.  The long-term repopulating subset of hematopoietic stem cells is deterministic and isolatable by phenotype. , 1994, Immunity.

[31]  G. Keller,et al.  Life span of multipotential hematopoietic stem cells in vivo , 1990, The Journal of experimental medicine.

[32]  I. Lemischka,et al.  Clonal and systemic analysis of long-term hematopoiesis in the mouse. , 1990, Genes & development.

[33]  J. Kurtzberg,et al.  Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. , 1989, The New England journal of medicine.

[34]  N. Brons,et al.  Isolation of hemopoietic stem cell subsets from murine bone marrow: I. Radioprotective ability of purified cell suspensions differing in the proportion of day-7 and day-12 CFU-S. , 1988, Experimental hematology.

[35]  M. Magli,et al.  Transient nature of early haematopoietic spleen colonies , 1982, Nature.

[36]  F. Monette,et al.  THE RELATIONSHIP BETWEEN STEM CELL SEEDING EFFICIENCY AND POSITION IN CELL CYCLE , 1979, Cell and tissue kinetics.

[37]  J. Till,et al.  HEMATOPOIETIC CELLS AND THE LYPHOID SYSTEM cells , 2003 .